2-(BROMOMETHYL)-4-METHYL-1-NITROBENZENE, 95%, 500mg

(S)-(+)-4-Phenyl-2-oxazolidinone>99.0%(GC)25g

Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1), 99%, 50mg

1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 97.0%, 5g

S-acetyl-PEG4-propargyl, 100mg

1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-1,2,4-TRIAZOLE, 95.0%, 250mg

Cartouches SPE CHROMAFIX® HR-P, 0,4 ml, petite, 50 pièce(s)

(4R)-2-[2-[BIS[4-(TRIFLUOROMETHYL)PHENYL]PHOSPHINO]-5-(TRIFLUOROMETHYL)PHENYL]-4-TERT-BUTYL-4,5-DIHYDROOXAZOLE, 95%, 1g

5-Bromobenzo[de]isochromene-1,3-dione, 95.0%, 2.5g

Thianthrene>98.0%(GC)5g

3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 97.0%, 250mg

3-ethyl-2-hydrazinoquinazolin-4(3H)-one, 250mg

(R)-2-(4-Fluorophenyl)pyrrolidine, 95.0%, 100mg